An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

As a type of regulated cell death (RCD), immunogenic cell death (ICD) can initiate the adaptive immune responses. Numerous reports highlight the capacity of ICD to alter the tumor immune microenvironment by releasing Damage-Associated Molecular Patterns (DAMP) or danger signals to boost the efficacy...

Full description

Bibliographic Details
Main Authors: Xinghe Liao, Hui Liu, Zhe Zhang, Jing Zhang, Chenyue Zhang, Weiwei Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1010787/full
_version_ 1828322203576303616
author Xinghe Liao
Xinghe Liao
Hui Liu
Zhe Zhang
Zhe Zhang
Jing Zhang
Jing Zhang
Chenyue Zhang
Chenyue Zhang
Weiwei Zhao
Weiwei Zhao
author_facet Xinghe Liao
Xinghe Liao
Hui Liu
Zhe Zhang
Zhe Zhang
Jing Zhang
Jing Zhang
Chenyue Zhang
Chenyue Zhang
Weiwei Zhao
Weiwei Zhao
author_sort Xinghe Liao
collection DOAJ
description As a type of regulated cell death (RCD), immunogenic cell death (ICD) can initiate the adaptive immune responses. Numerous reports highlight the capacity of ICD to alter the tumor immune microenvironment by releasing Damage-Associated Molecular Patterns (DAMP) or danger signals to boost the efficacy of immunotherapy. Therefore, identification of the ICD-associated biomarkers is crucial for the prediction of ICD-induced immune responses. In this report, the consensus clustering technique was used to identify two subcategories (subtypes) linked to ICD. In comparison to the ICD-low subcategory, the ICD-high subcategory showed longer survival and more immune cell infiltration. Then, a novel ICD-associated prognostic model was developed and validated for predicting the survival of patients with breast invasive carcinomas (BRCA) and is linked to the tumor immune microenvironment. To conclude, a novel ICD-based BRCA classification scheme was designed. For individuals with BRCA, this categorization will be crucial for directing the assessment of prognosis and treatment.
first_indexed 2024-04-13T18:37:38Z
format Article
id doaj.art-082fb15599ba45e4bc9b8ab667e1c13e
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-13T18:37:38Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-082fb15599ba45e4bc9b8ab667e1c13e2022-12-22T02:34:50ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-10-011310.3389/fgene.2022.10107871010787An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapyXinghe Liao0Xinghe Liao1Hui Liu2Zhe Zhang3Zhe Zhang4Jing Zhang5Jing Zhang6Chenyue Zhang7Chenyue Zhang8Weiwei Zhao9Weiwei Zhao10Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Neurology, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaAs a type of regulated cell death (RCD), immunogenic cell death (ICD) can initiate the adaptive immune responses. Numerous reports highlight the capacity of ICD to alter the tumor immune microenvironment by releasing Damage-Associated Molecular Patterns (DAMP) or danger signals to boost the efficacy of immunotherapy. Therefore, identification of the ICD-associated biomarkers is crucial for the prediction of ICD-induced immune responses. In this report, the consensus clustering technique was used to identify two subcategories (subtypes) linked to ICD. In comparison to the ICD-low subcategory, the ICD-high subcategory showed longer survival and more immune cell infiltration. Then, a novel ICD-associated prognostic model was developed and validated for predicting the survival of patients with breast invasive carcinomas (BRCA) and is linked to the tumor immune microenvironment. To conclude, a novel ICD-based BRCA classification scheme was designed. For individuals with BRCA, this categorization will be crucial for directing the assessment of prognosis and treatment.https://www.frontiersin.org/articles/10.3389/fgene.2022.1010787/fullimmunogenic cell deathbreast invasive carcinomaprognosistumor immune microenvironmentbiomarker
spellingShingle Xinghe Liao
Xinghe Liao
Hui Liu
Zhe Zhang
Zhe Zhang
Jing Zhang
Jing Zhang
Chenyue Zhang
Chenyue Zhang
Weiwei Zhao
Weiwei Zhao
An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
Frontiers in Genetics
immunogenic cell death
breast invasive carcinoma
prognosis
tumor immune microenvironment
biomarker
title An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
title_full An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
title_fullStr An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
title_full_unstemmed An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
title_short An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
title_sort immunogenic cell death associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
topic immunogenic cell death
breast invasive carcinoma
prognosis
tumor immune microenvironment
biomarker
url https://www.frontiersin.org/articles/10.3389/fgene.2022.1010787/full
work_keys_str_mv AT xingheliao animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT xingheliao animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT huiliu animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT zhezhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT zhezhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT jingzhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT jingzhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT chenyuezhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT chenyuezhang animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT weiweizhao animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT weiweizhao animmunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT xingheliao immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT xingheliao immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT huiliu immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT zhezhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT zhezhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT jingzhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT jingzhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT chenyuezhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT chenyuezhang immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT weiweizhao immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy
AT weiweizhao immunogeniccelldeathassociatedclassificationpredictionsareimportantforbreastinvasivecarcinomaprognosisandimmunotherapy